Table 15 In vitro activity zone of inhibition (mm) of compounds
From: Biological potential of thiazolidinedione derivatives of synthetic origin
Compounds | Gram-positive bacteria | Gram-negative bacteria | Fungi | |||
|---|---|---|---|---|---|---|
S. aureus | S. epidermidis | E. coli | P. aeruginosa | A. niger | A. fumigates | |
48 | 18 (1.9) | 16 (1.4) | 28 (1.6) | 28 (0.56) | 20 (8.8) | 26 (2.3) |
49 | 21 (22.1) | 27 (22.2) | 27 (21.5) | 21 (21.5) | 24 (20.7) | 20 (22.6) |
50 | 16 (2.7) | 18 (3.39) | 22 (9.2) | 16 (1.4) | 22 (8.2) | 26 (3.4) |
51 | 21 (22.1) | 25 (22.2) | 25 (21.5) | 21 (21.5) | 28 (21.6) | 25 (21.7) |
Ciprofloxacin | 29 (0.2) | 31 (0.39) | 32 (0.2) | 33 (0.25) | – | – |
Ketoconazole | – | – | – | – | 26 (6.1) | 24 (0.23) |